Loading…
Asston Pharmaceuticals (BSE 544445)₹151.25+7.19%Pharmaceuticals
Asston Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 33.3 against a peer median of 20.2, and ROCE of 16.8% against a peer median of 11.1%, and latest-quarter sales growth of 10.8% against a peer median of 25.3%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs BSE 544445 |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs BSE 544445 |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 544445 |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs BSE 544445 |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs BSE 544445 |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs BSE 544445 |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | — |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs BSE 544445 |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 544445 |
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | vs BSE 544445 |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | vs BSE 544445 |
| Peer median | 129 | 20.2 | 11.1 | 11.1 | 0.55 | 0.0 | 106 | 6 | 25.3 | 43.5 |
Listed companies closest to Asston Pharmaceuticals in Pharmaceuticals include Par Drugs and Chemicals, Speciality Medicines, Parnax Lab, Bal Pharma, Lactose (India), Krebs Biochemicals and Industries, BALAXI PHARMACEUTICALS, Parnax Lab.
Par Drugs and Chemicals, with a market cap of ₹139 Cr.
Asston Pharmaceuticals trades at a P/E of 33.3; the median of its peer set is 20.2. A P/E above or below the median is a description, not a judgement on value.
Asston Pharmaceuticals' return on capital employed is 16.8%, above the peer median of 11.1%.